Title of article
Intravenous ancrod for acute ischaemic stroke in the European Stroke Treatment with Ancrod Trial: a randomised controlled trial
Author/Authors
Michael G Hennerici، نويسنده , , Richard Kay، نويسنده , , Julien Bogousslavsky، نويسنده , , Gian Luigi Lenzi، نويسنده , , Marc Verstraete، نويسنده , , Jean Marc Orgogozo and for the ESTAT investigators، نويسنده ,
Issue Information
روزنامه با شماره پیاپی سال 2007
Pages
8
From page
1871
To page
1878
Abstract
Background
Intravenous tissue plasminogen activator is the only approved specific treatment for acute ischaemic stroke. Ancrod, a natural defibrinogenating agent from snake venom, has proved to have a favourable effect when given within 3 h after an acute
Journal title
The Lancet
Serial Year
2007
Journal title
The Lancet
Record number
590578
Link To Document